Gastrointestinal Cancer Research

Bringing Promising Breakthroughs Directly to Patient Care

University Hospitals Seidman Cancer Center is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center. Our physicians are taking the lead in researching innovative therapies, new drugs and surgical techniques to treat gastrointestinal cancer.

National Trial of a Vaccine for Pancreatic Cancer

UH Seidman Cancer Center has enrolled more patients than any other study site for a nationwide clinical trial of a candidate vaccine for pancreatic cancer treatment. Seldom detected in its early stages, pancreatic cancer typically spreads rapidly. It is one of the leading causes of cancer deaths.

Pioneers in Advancing Gastrointestinal Cancer Treatment

Our gastrointestinal oncologists pioneered sphincter-preserving colorectal procedures that can eliminate the need for permanent colostomies. It was also a team of our physician-scientists that laid the groundwork for the use of predictive biomarkers in the treatment of colon cancer.

This valuable insight drives the development of emerging procedures and helps our physicians deliver more effective therapies. We are able to specifically target both radiation and medication treatments with advanced precision. Additionally, our revolutionary approach has the potential to reduce side effects and complications, while helping to cure some cases of gastrointestinal cancers.